Advancing Fibroid Care Saudi Center Evaluates Transradial Uterine Artery Embolization for Women with Symptomatic Fibroids

Introduction

Minimally invasive treatments are redefining the standards of women’s health. A recent clinical study from the Security Forces Hospital in Riyadh explores the safety and efficacy of transradial uterine artery embolization (UAE) for women suffering from symptomatic fibroids. This innovative procedure offers a non-surgical alternative with notable outcomes for patients prioritizing uterine conservation.

Key Highlights of the Study

  • Study Setting: Tertiary center in Saudi Arabia.
  • Participants: 23 women (mean age: 39) with symptomatic uterine fibroids.
  • Intervention: Transradial uterine artery embolization (UAE).
  • Follow-up Duration: Two years (initial phase of a 5-year study).

Findings in Focus

  • Average fibroid volume reduction: 49%.
  • Zero major complications recorded during the study period.
  • No symptom recurrence within the follow-up window.
  • Weak correlation between fibroid shrinkage and BMI, age, or fibroid count.

Other observations:

  • Common symptoms included abnormal bleeding (70% menorrhagia), anemia, pain, and infertility.
  • Most patients showed improvement in hemoglobin levels post-procedure.
  • Average hospital stay: 2–4 days, slightly longer than international norms due to strict protocols.

Clinical Implications and Broader Perspective

This study adds valuable evidence supporting the transradial approach as an effective and safer route for uterine artery embolization, especially for patients unwilling or unfit for surgery.

As noted by the Society of Interventional Radiology, embolization techniques should be integrated into mainstream care, offering women non-surgical pathways to relief from fibroid symptoms.

Further Reading and Resources

Call-to-Action

Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article.